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ONLINE EXCLUSIVE

Chronic Stress and Ovarian
Function in Female Childhood
Cancer Survivors
Theresa M. Hardy, PhD, RN, Mauricio Garnier-Villarreal, PhD, Jennifer M. Ohlendorf, PhD, RN,
and Donna O. McCarthy, PhD, RN

OBJECTIVES: To explore the relationships among
perceived stress, biomarkers of hypothalamic–
pituitary–adrenal (HPA) activity, gonadotropin
levels, and anti-Müllerian hormone (AMH) in female
childhood cancer survivors (CCSs).
SAMPLE & SETTING: 24 female CCSs from the Royal
Hospital for Sick Children in Edinburgh, Scotland,
were included in the study.
METHODS & VARIABLES: Perceived stress was
measured using the Perceived Stress Scale. HPA
activity was measured using salivary cortisol and
hair cortisol. Ovarian function was measured using
serum gonadotropin levels and serum AMH levels.
Latent growth curve modeling was used to determine
diurnal cortisol slope and intercept. Bayesian
structural equation modeling was used to explore the
relationship among perceived stress, biomarkers of
HPA activity, and ovarian function.
RESULTS: The authors found an inverse association
between perceived stress and ovarian function and
a positive association between biomarkers of HPA
activity and ovarian function.
IMPLICATIONS FOR NURSING: Further research is
needed to understand factors contributing to risk for
post-treatment reproductive dysfunction in female
CCSs.

KEYWORDS childhood cancer survivors; ovarian
function; biomarkers; perceived stress
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A

n estimated 1 in 1,000 adults aged
younger than 35 years is a survivor
of childhood cancer (Blumenfeld,
2012). Because of significant advances in the treatment of pediatric
cancer, the five-year survival rate exceeds 80% in the
United States (Phillips et al., 2015). With an increasing
number of survivors, there has been growing recognition of the late effects of cancer treatment (Kremer et
al., 2013). Among these, reproductive dysfunction is a
major concern for cancer survivors and is highly correlated with quality of life in this population (Cherven,
Mertens, Wasilewski-Masker, Williamson, & Meacham,
2015; Knopman, Papadopoulos, Grifo, Fino, & Noyes,
2010; Kondapalli et al., 2014; Letourneau, Chan, & Rosen, 2013). Among female childhood cancer survivors
(CCSs), 6% experience acute ovarian failure, and another 23% experience a significant reduction in ovarian
function (Salih et al., 2015).
In clinical practice, post-treatment ovarian function is assessed using a profile of hormones, including
follicle-stimulating hormone (FSH) and luteinizing
hormone (LH), plus the presence or absence of menses.
However, neither FSH nor menstrual cyclicity post–
cancer treatment are reliable predictors of future
fertility (Knight et al., 2015). Because risk of infertility
related to premature ovarian failure is associated with
the size of the ovarian follicle pool (ovarian reserve),
a biomarker that more closely reflects the number of
remaining follicles in the ovary would have significant
clinical potential. Anti-Müllerian hormone (AMH) is a
biomarker of the ovarian reserve; plasma levels reflect
the continuous noncyclic growth of small follicles and,
therefore, mirror the size of the remaining follicle pool
(Jeppesen et al., 2013). AMH is prematurely reduced
in CCSs (Anderson & Wallace, 2013; Charpentier
et al., 2014; Miyoshi et al., 2013) and may be an early
marker of significant gonadotoxicity post-treatment
(Brougham et al., 2012; Lie Fong et al., 2009). Although
studies have demonstrated the use of pretreatment
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AMH concentrations to predict risk of post-treatment
ovarian dysfunction in cancer survivors (Anderson
& Wallace, 2013; Lunsford, Whelan, McCormick, &
McLaren, 2014), its predictive value is limited because
of incomplete knowledge of factors that influence AMH
concentrations (Abusief, Missmer, Ginsburg, Weeks, &
Partridge, 2012; van Dorp et al., 2014).
Cancer survivors have high rates of psychological
stress and hypothalamic–pituitary–adrenal (HPA)
dysregulation (Oancea et al., 2014; Taylor, Absolom,
Snowden, & Eiser, 2012; Zeltzer et al., 2009). One
of the primary regulators of reproductive function
is the HPA axis. Psychological stress impairs reproductive function by activating the HPA axis, which
suppresses hypothalamic pituitary gonadal function
(Kalantaridou et al., 2010; Louis et al., 2011; Lynch,
Sundaram, Maisog, Sweeney, & Buck Louis, 2014;
Whirledge & Cidlowski, 2013). Increased HPA activity
is associated with elevated levels of glucocorticoids,
such as cortisol. At homeostatic levels, cortisol contributes to steroid biosynthesis and maintenance of
gonadotropin release; at elevated levels, it suppresses
gonadotropin-releasing hormone secretion, reduces
pulsatile LH secretion, and increases rates of follicle
atresia (Breen & Mellon, 2014; Whirledge & Cidlowski,
2013). Because higher rates of psychological stress
and reproductive dysfunction are observed in cancer
survivors, the purpose of this study was to explore
relationships among perceived stress, HPA activity,
and ovarian function in a sample of female CCSs.

Methods
The sample for this exploratory cross-sectional study
consisted of female CCSs aged from 16 to 35 years, who
were previously treated for cancer at the Edinburgh
Children’s Cancer Centre at the Royal Hospital for Sick
Children in Scotland. The inclusion criteria were female
patients treated for cancer at the Edinburgh Children’s
Cancer Centre who were aged younger than 18 years
at cancer diagnosis, were aged from 16 to 35 years at
the time of the study visit, were at least one year from
completing treatment, and signed written informed
consent. The exclusion criteria were a positive pregnancy test, ovarian surgery in the past six months,
hormonal therapy in the past three months (GnRH
agonists, recFSH), alcohol or drug abuse/dependence
according to ICD-10 criteria, or having received an
investigational drug in the past three months.
The Marquette University Institutional Review
Board and the South East Scotland Research Ethics
Committee approved this study. Data management
was compliant with the most current guidelines of the
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Health Insurance Portability and Accountability Act of
1996 and in full conformity with the principles of the
Declaration of Helsinki, in accordance with the principles laid down in the Convention of the Council of
Europe for the protection of human rights and dignity
of the human being. Original patient names and hospital
bar codes were deidentified by using a new, independent
numbering system for all study-related documentation.
A link-list was established and kept separate from other
study documentation. The link-list was only accessible
to the study investigators and was kept in a locked office
at the Royal Hospital for Sick Children.
Instruments

Assessment of ovarian function included serum
gonadotropin levels (LH and FSH), estradiol (E2), and
AMH. Serum levels of these hormones are routinely
measured during the annual follow-up appointment.
LH, FSH, and E2 levels are measured to screen for
gonadotropin deficiency and ovarian dysfunction
post–cancer treatment (Metzger et al., 2013). The
laboratory results were retrieved from participants’
medical records. Serum AMH levels were analyzed
using the Beckman Coulter AMH Gen II ELISA. The
AMH Gen II ELISA has a sensitivity of 0.57 pmol/L.
HPA activity was determined using measures of
salivary cortisol and hair cortisol. Salivary cortisol has
been used to measure HPA activity in cancer survivors
and other populations (Du et al., 2013; Ho, Fong, Chan,
& Chan, 2013; Sephton et al., 2013). Cortisol secretory
activity follows a diurnal pattern, with levels peaking
after awakening and lowest levels before going to bed
(Kirschbaum & Hellhammer, 1989). Chronic stress
is associated with alterations in the cortisol awakening response (Dedovic & Ngiam, 2015; Révész et al.,
2013) and blunting of the morning–evening diurnal
slope (Garland, Beck, Lipschitz, & Nakamura, 2015;
Ho et al., 2013; Schrepf et al., 2015). A commercially
available ELISA kit by Salimetrics® was used for the
quantification of cortisol in saliva. This cortisol assay
kit has a lower detection limit of 7 ng/dl. The mean
intra-assay coefficient is 5.7%, and the mean interassay coefficient is 10%.
Chronic stress has also been associated with elevated levels of cortisol in hair (Russell, Koren, Rieder,
& Van Uum, 2012; Wells et al., 2014). Hair has a predictable growth rate of 1 cm per month; the most
proximal 1 cm segment to the scalp approximates
the past month’s cortisol production, the second
most proximal segment the month prior to that,
and so on (Russell et al., 2012). Hair (3 cm) was processed for extraction of cortisol in the laboratory of
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Clemens-Kirschbaum in Dresden, Germany, as previously described (Kirschbaum, Tietze, Skoluda, &
Dettenborn, 2009).
Perceived stress was measured using the
Perceived Stress Scale (PSS-10) (Cohen, Kamarck,
& Mermelstein, 1983). The PSS-10 is a 10-item selfreport scale measuring life stress during the past four
weeks and is the most widely used measure of this
concept. The PSS-10 was designed for use in community samples of participants with education as
low as junior high. Good to excellent reliability has
been observed with the PSS-10 in varied populations
(Cohen et al., 1983), with a Cronbach alpha ranging
from 0.78–0.91 (Lee, 2012). The measure has been
demonstrated to reliably measure stress appraisal in
cancer survivors (Golden-Kreutz, Browne, Frierson,
& Andersen, 2009).

FIGURE 1. Bayesian Path Analysis Model
Diurnal cortisol intercept

Anti-Müllerian hormone
R2 = 0.332

Diurnal cortisol slope

Follicle-stimulating
hormone
R2 = 0.418

Perceived Stress Scale

Luteinizing hormone
R2 = 0.392

Hair cortisol

Estradiol
R2 = 0.000

Note. Covariates consist of age, body mass index, age at menarche,
and age at diagnosis.

Data Collection

Recruitment was conducted by sending letters of
invitation to female CCSs in long-term follow-up two
weeks prior to their annual review appointment. After
providing informed consent, saliva-collecting devices
and detailed instructions for collection of samples
were provided to participants at their appointment.
Participants were instructed not to eat, smoke, consume caffeine, or exercise for 30 minutes prior to
sample collection (Schrepf et al., 2015). Participants
provided three timed saliva samples for the analysis of
salivary cortisol: the first sample was collected before
going to bed on the night prior to the study visit, the
second immediately upon awakening the morning of
their visit before getting out of bed, and the third 30
minutes after the second sample. Participants were
instructed to record the time of saliva collection
on their saliva-collecting devices and to keep the
saliva samples refrigerated until coming in for their
study visit to preserve sample integrity. Participants
brought the three saliva samples to their study visit.
Samples were stored at the Royal Hospital for Sick
Children at –20ºC. Within a week of collection, a
research nurse picked them up and brought them to
the Queens Medical Research Institute, where they
were centrifuged and stored at –80ºC.
During the study visit, participants provided
demographic information, including age, ethnicity/
race, level of education, marital status, and employment status. The following clinical information
was retrieved from participants’ medical records:
cancer diagnosis, age at cancer diagnosis, chemotherapy/radiation received, and age at menarche.
Participants then completed the PSS-10 (Cohen et al.,
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1983). Lastly, participants provided a sample of hair
for measurement of hair cortisol. A small sample of
hair, 20 mg (100–150 strands), was taken from the
vertex posterior of the participant’s scalp using a new
pair of thinning shears (Hoffman, Karban, Benitez,
Goodteacher, & Laudenslager, 2014; Van Uum et al.,
2008). Hair length was recorded, and proximal ends
of the hair samples were marked. Hair samples were
stored in aluminum foil for protection before processing (Hoffman et al., 2014) and labeled with a unique
participant study ID.
Data Analysis and Interpretation

Means and standard deviations for all demographic
and clinical variables were reported to describe
the sample and reveal distributional characteristics. Latent growth curve modeling was used to
define diurnal cortisol change over time (three time
points). Change processes are determined by combining the underlying pattern of growth (slope) with
the initial or baseline measurement (intercept). The
intercept and slope were then incorporated into the
overall model as independent predictors of ovarian
function.
Bayesian structural equation modeling (SEM) was
used to explore the relationship between perceived
stress and HPA activity and to explore relationships
between perceived stress, biomarkers of HPA activity,
gonadotropin levels, and AMH (see Figure 1). Bayesian
SEM was selected because it facilitates greater precision in estimating the posterior distribution of the
parameters for small samples. The posterior distribution describes the best estimate of the parameters
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given the data and the level of uncertainty about the
respective parameter by the width of it, represented
by the credible interval (Yuan & MacKinnon, 2009).
Bayesian SEM also offers the advantage of incorporating previous knowledge about the model’s parameters
through the use of priors. The term “prior” is used to
refer to the expected parameter distribution based on
theory or previous research. Given the exploratory
nature of this study, the authors examined the model
parameters using weakly informed priors. Weakly
informed priors are not intended to guide the parameters, but rather to provide information to delimitate
the most likely data space for the parameters. The
authors used a special case of SEM called path analysis. In path analysis, every variable in the model is
directly measured or observed (Bryan, Schmiege,
& Broaddus, 2007). The authors ran path analysis
models with salivary cortisol intercept and slope,
PSS-10, hair cortisol, body mass index, age, age at
diagnosis, and age at menarche as predictors and with
AMH, E2, FSH, and LH as outcomes.
Data augmentation was used to account for missing data. Missing data were treated simultaneously as
a parameter and data, filling any missing data points
with the most likely value given the posterior distribution (Merkle, 2011). Data analysis was conducted in
R (Core Team, 2017). Bayesian path analysis was run
with the blavaan R package (Merkle & Rosseel, 2018),
which estimates the model with the general Bayesian
software JAGS (Plummer, 2003). Convergence of
the Markov chains was determined using the potential scale reduction factor, also known as univariate
R-hat (Gelman & Rubin, 1992). Model convergence
was achieved when R-hat was lower than 1.1 for every

parameter (Brooks & Gelman, 1998). The model was
run with three chains, keeping the last 5,000 iterations
from each chain to build the posterior distributions.

Results

—

Twenty-four female CCSs (X age = 21.79 years,
SD = 5.68) participated in the study. The majority had at least a high school education (n = 15) and
were unmarried (n = 19) (see Table 1). Childhood
cancer diagnoses varied considerably and included
osteosarcoma (n = 1), rhabdomyosarcoma (n =
5), Wilms tumor (n = 1), optic chiasmal glioma (n = 1),
non-Hodgkin lymphoma (n = 3), Ewing sarcoma (n =
2), immature teratoma of the left ovary (n = 1), B-cell
lymphoma (n = 1), Hodgkin lymphoma (n = 4), right
temporal lobe pilocytic astrocytoma (n = 1), pilocytic
astrocytoma of the conus (n = 1), left renal tumor (n =
1), undifferentiated sarcoma of posterior sacral region
(n = 1), and acute lymphoblastic leukemia (n = 1).
Cancer treatments included chemotherapy only (n =
11), radiation only (n = 1), chemotherapy and radiation (n = 8), or other treatment (n = 4). Mean length
of treatment was 0.63 years (SD = 1.05).
Latent Growth Curve

The average salivary cortisol intercept (corresponding to the night time point) was 105.25 ng/dl, with a
variance of 48.53 ng/dl. On average, salivary cortisol
levels increased 24.19 ng/dl per hour with a variance of
9.41 ng/dl. The latent growth curve demonstrated heterogeneity of variance over time (see Figure 2), with
increased variability observed at the later time points.
Some slopes were positive and others flat, creating an
overdispersion at the later time points.

TABLE 1. Clinical and Demographic Descriptive Statistics

E78

Variable

N

Range

X

—

SD

Age (years)
Age at diagnosis (years)
Age at menarche (years)
Body mass index (kg/m2)
Perceived Stress Scale total
Night cortisol (ng/dl)
Morning cortisol (ng/dl)
Morning cortisol plus 30 minutes (ng/dl)
Hair cortisol (pg/mg)
Follicle-stimulating hormone (U/L)
Luteinizing hormone (U/L)
Estradiol (pmol/L)
Anti-Müllerian hormone (pmol/L)

24
24
22
20
23
20
21
21
24
24
24
24
23

17–34
1–16
10–15
19.96–34.38
6–32
18.92–262.66
32.63–644.01
26.24–850.89
1.08–211.7
0.7–9.8
0.5–10.7
50–685
2.4–79.5

21.79
10.38
12.27
24.57
16.43
105.26
318.74
392.93
19.94
4.93
4.53
197.88
23.28

5.68
5.22
1.19
3.81
6.73
74.68
203.46
263.68
43.23
2.34
3.12
175.04
17.94
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The authors found that the model predictors (i.e.,
salivary cortisol intercept, salivary cortisol slope, hair
cortisol, and PSS-10) explained 42% of the variance of
FSH, 39% of LH, 33% of AMH, and 0% of E2. The standardized regression coefficients allowed the authors
to compare the effect of different predictors for each
outcome. For AMH, age, age at diagnosis, perceived
stress, and hair cortisol levels were the strongest predictors. For FSH, perceived stress was the strongest
predictor, followed by the intercept of salivary cortisol and age at menarche. For LH, the authors found
that the three predictors related to cortisol (i.e., salivary cortisol intercept, salivary cortisol slope, and
hair cortisol) and age at diagnosis were the strongest
predictors. For E2, all predictors were equivalent
around 0, demonstrating that these predictors did not
characterize the behavior of E2.

Discussion
In this small sample of female CCSs, the mean PSS-10
score was 16.43 (SD = 6.73), which is higher than the
mean threshold for stress in the general population
(13.7 for women) (Cohen et al., 1983). Surviving a
life-threatening illness, such as pediatric cancer,
represents a major early life stressor (Laufer et al.,
2012). Several studies have demonstrated that CCSs
report higher levels of stress than healthy controls
(Brown, Madan-Swain, & Lambert, 2003; Oancea et
al., 2014). Keir, Swartz, and Friedman (2007) demonstrated that long-term cancer survivors are just as
likely as patients with cancer to report high levels of
stress, suggesting that the time since diagnosis and
treatment does not mitigate the psychological stress
experienced by cancer survivors.
The authors observed higher mean night salivary
cortisol concentrations (greater than 100 ng/dl) and
flattened diurnal cortisol slopes in the current sample
of female CCSs. In healthy individuals, cortisol concentrations peak in the morning about 30 minutes after
awakening and decline throughout the day (Bergen et
al., 2012). Higher nighttime cortisol levels and blunted
cortisol slopes are abnormal diurnal patterns. It is
hypothesized that these abnormal diurnal patterns
induce systemic inflammation, which is associated
with increased incidence of adverse long-term health
outcomes for cancer survivors (e.g., cancer recurrence,
chronic symptom experience) (Schrepf et al., 2015).
To the authors’ knowledge, no studies have examined hair cortisol levels in CCSs. In this small sample
of 24 CCSs, the authors found a wide range of threemonth hair cortisol concentrations (range = 1.08–211.7
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FIGURE 2. Diurnal Cortisol Slopes at Three
Time Points
1,000

800
Salivary Cortisol (ng/dl)

Bayesian Structural Equation Modeling

600

400

200

0

1

2

Time Point
0—night time; 1—awakening; 2—awakening plus 30 minutes
Note. Each line corresponds to a different participant.

—

pg/mg, X = 19.94 pg/mg, SD = 43.23 pg/mg). There was
one outlier in the sample (211.7 pg/mg); excluding
the outlier, the range of hair cortisol concentrations
was 1.08 pg/mg to 55.71 pg/mg. Age may contribute
to changes in hair cortisol concentrations (Gow,
Thomson, Rieder, Van Uum, & Koren, 2010); however,
no association between age and cortisol concentrations was observed in the current sample. The mean
hair cortisol concentration observed in this sample
is lower than the mean reported in healthy samples
(Stalder & Kirschbaum, 2012). In a meta-analysis of
chronic stress and HPA activity, Miller, Chen, and
Zhou (2007) reported that patterns of HPA activity
in response to chronic stress vary by time since onset.
When the eliciting stimulus of a chronic stressor first
begins, there is an initial activation of the HPA axis,
which results in elevated concentrations of cortisol. As time passes, this activity lessens, and cortisol
secretion rebounds to below normal (Miller et al.,
2007). This may explain the lower mean hair cortisol concentrations observed in this sample of CCSs.
Because hypocortisolism and hypercortisolism are
associated with adverse health outcomes, the finding of lower mean hair cortisol concentrations in this
sample is notable and requires further investigation
(Miller et al., 2007).
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In this study of 24 CCSs, the authors found that
the model predictors explained 33% of the variation
in AMH levels, with the highest standardized regression coefficients observed for age, age at diagnosis,
perceived stress, and hair cortisol (see Table 2). AMH
was inversely associated with age, age at diagnosis,
and perceived stress; with an increase of one standard

deviation in age, age at diagnosis, and perceived stress
score, AMH declined 5.66 pmol/L, 5.19 pmol/L, and
5.02 pmol/L, respectively. The inverse association
between age and AMH is well established in the literature (Kelsey, Wright, Nelson, Anderson, & Wallace,
2011). Barton et al. (2013) also found that older age at
diagnosis increased risk of post-treatment infertility

TABLE 2. Bayesian Path Analysis by Outcome
Predictor

b

95% CI

Standardized Estimate

4.138
5.26
–5.02
3.757
1.955
–5.664
–5.187
2.996

[–10.39, 18.81]
[–7.14, 18.28]
[–10.93, 1.58]
[–2.43, 10.57]
[–4.65, 8.29]
[–12.37, 1.18]
[–11.86, 1.86]
[–3.77, 9.32]

0.133
0.082
–0.287a
0.214a
0.112
–0.312a
–0.289a
0.172

1.04
0.286
–1.332
0.381
0.294
0.153
0.113
0.571

[–6.31, 8.45]
[–5.6, 6.61]
[–2.47, –0.05]
[–0.93, 1.65]
[–0.99, 1.54]
[–1.22, 1.51]
[–1.32, 1.52]
[–0.77, 1.7]

0.233a
0.031
–0.53a
0.151
0.117
0.058
0.044
0.228a

2.259
2.802
–0.537
0.814
–0.384
–0.43
0.857
–0.091

[–8.73, 13.95]
[–7.85, 10.18]
[–2.08, 1.04]
[–0.88, 2.87]
[–2.4, 1.65]
[–2.48, 1.46]
[–1.34, 2.87]
[–1.67, 1.55]

0.387a
0.233a
–0.164
0.247a
–0.117
–0.126
0.254a
–0.028

0.14
1.065
0.749
–0.535
0.589
–0.1
–0.96
–1.115

[–13.51, 14.35]
[–13.37, 14.36]
[–12.59, 14.75]
[–14.05, 13.34]
[–13.15, 13.94]
[–14.03, 13.36]
[–14.56, 12.92]
[–14.54, 12.86]

0.00
0.001
0.003
–0.002
0.002
–0.00
–0.004
–0.005

Anti-Müllerian hormone
Salivary cortisol intercept
Salivary cortisol slope
Perceived Stress Scale
Hair cortisol
Body mass index
Age
Age at diagnosis
Age at menarche
Follicle-stimulating hormone
Salivary cortisol intercept
Salivary cortisol slope
Perceived Stress Scale
Hair cortisol
Body mass index
Age
Age at diagnosis
Age at menarche
Luteinizing hormone
Salivary cortisol intercept
Salivary cortisol slope
Perceived Stress Scale
Hair cortisol
Body mass index
Age
Age at diagnosis
Age at menarche
Estradiol
Salivary cortisol intercept
Salivary cortisol slope
Perceived Stress Scale
Hair cortisol
Body mass index
Age
Age at diagnosis
Age at menarche

Predictors with the highest standardized regression coefficients
CI—confidence interval
a
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in CCSs, but only in unadjusted models (Barton et al.,
2013). The association among perceived stress, HPA
activity, and the ovarian reserve has not been examined
in CCSs. However, Pal, Bevilacqua, and Santoro (2010)
examined the association between AMH levels and
chronic psychosocial stress in 89 premenopausal infertile women. The study found that women with chronic
stress demonstrated significantly lower AMH levels (p =
0.034) and were three times more likely to be diagnosed with diminished ovarian reserve (p = 0.025). Pal
et al. (2010) concluded that chronic psychosocial stress
was associated with diminished ovarian reserve. The
study proposed HPA dysregulation as a plausible explanation for this association; because a biomarker of
chronic stress was not included in the study, the study
was unable to provide evidence supporting this theory.
In the current study, the authors found that, with
an increase of one standard deviation in hair cortisol
concentrations, AMH increased 3.76 pmol/L. Although
the standardized regression coefficients of the diurnal
cortisol intercept and slope were lower, they were also
positively associated with AMH levels. Taken together
(positive associations among hair cortisol concentrations, diurnal cortisol intercept and slope, and AMH
levels), these findings suggest a positive association
between cortisol concentrations and the ovarian
reserve, and support the hypothesis that threshold
glucocorticoid levels are necessary to sustain ovarian
function (Whirledge & Cidlowski, 2013). As stated
previously, the authors found lower mean hair cortisol
concentrations in the current sample than reported in
healthy populations (Stalder & Kirschbaum, 2012).
More than half of the participants in the sample
exhibited flattened diurnal cortisol slopes. Lower daily
cortisol output and flattened diurnal cortisol slopes
have been observed in cancer survivors. These findings
are consistent with prior studies linking hypocortisolism to increased risk of experiencing late effects of
cancer treatment (Bower et al., 2005; Cuneo et al., 2017;
Ho et al., 2013; Schrepf et al., 2015; Sephton et al., 2013).
In this study, the authors found that the model predictors explained 42% of the variation in FSH levels,
with the highest standardized regression coefficients
observed for salivary cortisol intercept, perceived
stress, and age at menarche. The model predictors explained 39% of the variation in LH levels, with the highest standardized regression coefficients observed for
salivary cortisol intercept and slope, hair cortisol, and
age at diagnosis. The authors also found that perceived
stress was inversely associated with FSH and LH levels.
Because the authors were unable to time the collection of reproductive hormone levels according to
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KNOWLEDGE TRANSLATION
ɐɐ Perceived stress should be assessed in female childhood cancer
survivors (CCSs) who report reproductive issues.
ɐɐ Hair cortisol may provide a convenient, noninvasive means of
assessing hypothalamic–pituitary–adrenal activity in CCSs.
ɐɐ Providers should consider factors other than diagnosis and
treatment-related variables when counseling CCSs regarding their
future fertility.

menstrual cycle phase, a strong association among
perceived stress and FSH and LH levels was not
anticipated. Several possible explanations exist for
the strong inverse association the authors observed
irrespective of menstrual cycle phase. It may be that
perceived stress has a significant effect on ovarian
function regardless of menstrual cycle phase (Schliep
et al., 2015). Another explanation may be that stress
perception varies across the menstrual cycle, such
that the degree to which a woman perceives her life
to be stressful is, in part, influenced by fluctuations
in gonadotropin levels (Duchesne & Pruessner, 2013).
Although perceived stress was inversely associated with FSH and LH, the authors found that HPA
activity (hair cortisol, salivary cortisol intercept, and
salivary cortisol slope) was positively associated with
FSH and LH levels. The findings support the role
of glucocorticoids in regulating the hypothalamic–
pituitary–gonadal axis (Whirledge & Cidlowski,
2013). Another explanation is that cortisol levels may
fluctuate across the menstrual cycle, as has been suggested by other studies (Kirschbaum, Kudielka, Gaab,
Schommer, & Hellhammer, 1999; Nepomnaschy et
al., 2011; Stephens, Mahon, McCaul, & Wand, 2016;
Wolfram, Bellingrath, & Kudielka, 2011). Although
preliminary, the findings from this small sample
support an association among perceived stress, HPA
activity, and gonadotropin levels in female CCSs.
More research is needed to clarify the mechanism
behind this association and to determine whether
it varies depending on the temporal nature of the
stressor and menstrual cycle phase.
Limitations

This exploratory study has several limitations. Because
of the small sample, the authors were unable to adjust
for hormonal contraceptive use in the overall model.
Hormonal contraceptive use is associated with suppression of FSH and LH levels, as well as increased
production of corticosteroid-binding globulin and
subsequent decreases in unbound cortisol levels
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(Stephens et al., 2016). Further research with larger
sample sizes is needed to control for the effects of contraceptive use on ovarian function and HPA activity in
female CCSs. In addition, because of the wide variety
of pediatric cancer diagnoses in this small sample, the
authors could not adjust for cancer diagnosis- and
treatment-related factors in the model. Several studies have found a significant effect of diagnosis- and
treatment-related factors on post-treatment ovarian function, including the cancer pathology itself
(van Dorp et al., 2014), the therapeutic regimen
(Charpentier et al., 2014), and the length of exposure
(El-Shalakany, Ali, Abdelmaksoud, Abd El-Ghany, &
Hasan, 2013; Reinmuth et al., 2013). Another limitation is that, because of the great distance that many
of the participants needed to travel, the authors were
unable to time study visits to coincide with a specific
menstrual cycle phase. For this reason, the authors
were unable to adjust gonadotropin and reproductive
hormone levels to account for menstrual cycle phase.
Lastly, the study design was cross-sectional and relied
on a convenience sample. The study’s findings require
validation in larger longitudinal studies.

Implications for Nursing
Reproductive dysfunction is a major concern for
cancer survivors and is highly correlated with quality of life in this vulnerable population (Cherven et
al., 2015; Knopman et al., 2010; Kondapalli et al.,
2014; Letourneau et al., 2013). However, studies
have demonstrated that cancer survivors are about
half as likely to be treated for infertility as their siblings (Barton et al., 2013). Although the reasons for
this discrepancy are not fully understood, healthcare
providers may perceive fertility treatments to be less
successful in this population. The guidelines from the
American Society for Clinical Oncology recommend
that options for fertility preservation be discussed
with patients with cancer at the earliest opportunity
(Knight et al., 2015; Letourneau et al., 2013). Oncology
nurses play an important role in advocating for cancer
survivors, helping to initiate conversations regarding
future fertility as early as possible, and discussing
factors that may mitigate the risk for post-treatment
reproductive dysfunction. The findings from this
study suggest that there may be modifiable factors,
such as chronic stress, that contribute to risk for
infertility post-treatment. Oncology nurses can minimize the potential burden of late effects by educating
patients regarding their risk and what actions can be
taken prior to or after treatment to reduce this risk
(McClellan et al., 2013).

E82

ONCOLOGY NURSING FORUM MAY 2019, VOL. 46, NO. 3

Conclusion
In this exploratory study, the authors sought to examine the association between chronic stress and ovarian
function in survivors of childhood cancer. Although
there is prior evidence suggesting stress affects gonadotropin hormone levels, the effects of chronic stress on
the ovarian reserve and its biomarker AMH are poorly
understood. The findings from this study provide preliminary evidence to suggest that perceived stress is
negatively associated with ovarian function and that
biomarkers of HPA activity are positively associated
with ovarian function in female CCSs. Few studies have
examined predictors of the ovarian reserve in CCSs
apart from diagnosis- and treatment-related factors.
The findings from this study provide the foundation for
further research examining the risk for post-treatment
reproductive dysfunction in female CCSs.
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